David Meyer, MD | |
1060 Gaffney Rd, #7440, Commander, Usa-meddac-ak, Attn:mcuc-mmd-qm, Ft. Wainwright, AK 99703 | |
(907) 353-5418 | |
(907) 353-4847 |
Full Name | David Meyer |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 1060 Gaffney Rd, #7440, Ft. Wainwright, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477646933 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 12815 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
David Meyer, MD 1060 Gaffney Rd, #7440, Commander, Usa-meddac-ak, Attn:mcuc-mmd-qm, Ft. Wainwright, AK 99703 Ph: (907) 353-5418 | David Meyer, MD 1060 Gaffney Rd, #7440, Commander, Usa-meddac-ak, Attn:mcuc-mmd-qm, Ft. Wainwright, AK 99703 Ph: (907) 353-5418 |
News Archive
he Global Polio Eradication Initiative on Tuesday launched its Global Polio Eradication and Endgame Strategic Plan in Washington, D.C.
Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical, food and feed industries, announced today details regarding its new Bakenzyme project.
Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.
Today the Department of Health and Human Services announced that Geisinger Health System will receive $16 million to create the Keystone Beacon Community as part of HHS's Beacon Community cooperative program.
A new report from Action on Hearing Loss has showed that there is a real demand for better technology solutions to help people with hearing loss overcome communication challenges when confronted by background noise.
› Verified 6 days ago